Yu-Ting Wu, Dong Chen, Liang Han, Shao-Liang Jiang, Jie-Hua Shi, Li Li, Wang-Cai Chen, Jia-Ping Huang
Journal: Biochimica et biophysica acta. General subjects 2024;1868(11):130712
PMID: 39313164
Palbociclib, a selective CDK4/6 inhibitor with potent anti-tumor effects, was investigated for its interaction with human α1-acid glycoprotein (HAG). Spectral analysis revealed that palbociclib forms a ground state complex with HAG, exhibiting binding constant (K) of 10 M at the used temperature range. The interaction between the two was determined to be driven mainly by hydrogen bonding and hydrophobic forces. Multispectral studies indicated that the bound palbociclib altered the secondary structure of HAG and reduced polarity around Trp and Tyr amino acids. And, molecular docking and dynamics simulations verified the experimental findings. Finally, most of the metal ions present in plasma, such as K, Cu, Ca, Mg, Ni, Fe, and Co, are detrimental to the binding of palbociclib to HAG, with the exception of Zn, which is favorable.
Copyright © 2024 Elsevier B.V. All rights reserved.
Miscellaneous:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.